Facebook
Twitter
LinkedIn
ForwardA Deeper Dive into the CDC Guidelines: Implementation and Practice
This module provides a detailed and practical approach to implementing the CDC Clinical Practice Guidelines Recommendations 1 through 10 in clinical practice with case examples. The remainder of the webinar addresses opioid stewardship and how to universally apply the guidelines at a practice level and at an individual level.
Target Audience
MDs/DOs
Primary Care
Emergency Medicine
Hospitalist
Surgeons
OB/GYNs
Neurologist
Dentists and Oral Surgeons
Physical medicine and rehabilitation
Occupational medicine
Pharmacists
Nurse practitioners and other advanced- practice registered nurses
Physician assistants
Learning Objectives
Engage in patient-centered, non-stigmatizing risk-benefit discussions and controlled substances agreements
Educate patients regarding goals of treatment and pros/cons of opioid continuation versus weaning
Implement weaning and/or rotation strategies that support patients, reduce opioid risk, and maximize efficacy
Joshua Blum MD is a primary care internist and addiction medicine physician at Denver Health and Hospital Authority. He is an institutional quality officer for pain and opioid management and works on initiatives to increase access to addiction treatment in the primary care setting. Dr. Blum is co-chair of the Provider Education Workgroup at the Colorado Consortium for Prescription Drug Abuse Prevention and serves on the leadership board of the Colorado Pain Society.
Dr Kaylin Klie is a family medicine and addiction medicine physician at the University of Colorado and Denver Health. Her clinical focus is perinatal addiction which includes the care of families impacted by substance use. Dr Klie enjoys teaching students, residents, fellows, and the community about caring for people with substance use conditions. She is the program director of the Addiction Medicine Fellowship at the University of Colorado School of Medicine. She serves on various local, regional, and national committees dedicated to serving and improving care for people with substance use.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Compass Healthcare Collaborative and Colorado Consortium for Prescription Drug Abuse Prevention. Compass Healthcare Collaborative is accredited by the IMS to provide continuing medical education for physicians.
Designation: Compass designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: Compass adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.
Available Credit
- 1.00 AMA PRA Category 1 Credit™